Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Influenza

  Free Subscription


Articles published in Arch Virol

Retrieve available abstracts of 74 articles:
HTML format



Single Articles


    November 2021
  1. VIJAYAKUMAR P, Raut AA, Chingtham S, Murugkar HV, et al
    Proteomic analysis of differential expression of lung proteins in response to highly pathogenic avian influenza virus infection in chickens.
    Arch Virol. 2021 Nov 16. pii: 10.1007/s00705-021-05287.
    PubMed     Abstract available


  2. TSUNEKI-TOKUNAGA A, Kondo T, Kanai K, Itagaki A, et al
    Local spread of influenza A (H1N1) viruses without a mutation for the maximum duration of an epidemic season in Japan.
    Arch Virol. 2021 Nov 11. pii: 10.1007/s00705-021-05301.
    PubMed     Abstract available


  3. WANG S, Liu Y, Yu L, Liang T, et al
    A strain of highly pathogenic porcine reproductive and respiratory syndrome virus: genomic characterization, pathogenicity, and construction of an infectious full-length cDNA clone.
    Arch Virol. 2021;166:3127-3141.
    PubMed     Abstract available


  4. RASTEGAR M, Samadizadeh S, Yasaghi M, Moradi A, et al
    Functional variation (Q63R) in the cannabinoid CB2 receptor may affect the severity of COVID-19: a human study and molecular docking.
    Arch Virol. 2021;166:3117-3126.
    PubMed     Abstract available


  5. DU X, Wu G, Zhu Y, Zhang S, et al
    Exploring the epidemiological changes of common respiratory viruses since the COVID-19 pandemic: a hospital study in Hangzhou, China.
    Arch Virol. 2021;166:3085-3092.
    PubMed     Abstract available


  6. RODRIGUEZ-MALDONADO AP, Vazquez-Perez JA, Cedro-Tanda A, Taboada B, et al
    Emergence and spread of the potential variant of interest (VOI) B.1.1.519 of SARS-CoV-2 predominantly present in Mexico.
    Arch Virol. 2021;166:3173-3177.
    PubMed     Abstract available


    October 2021
  7. JANG Y, Seo SH
    H5 cleavage-site peptide vaccine protects chickens from lethal infection by highly pathogenic H5 avian influenza viruses.
    Arch Virol. 2021 Oct 25. pii: 10.1007/s00705-021-05284.
    PubMed     Abstract available


  8. DOMNICH A, De Pace V, Pennati BM, Caligiuri P, et al
    Evaluation of extraction-free RT-qPCR methods for SARS-CoV-2 diagnostics.
    Arch Virol. 2021;166:2825-2828.
    PubMed     Abstract available


  9. HU J, Stojanovic J, Yasamineh S, Yasamineh P, et al
    The potential use of microRNAs as a therapeutic strategy for SARS-CoV-2 infection.
    Arch Virol. 2021;166:2649-2672.
    PubMed     Abstract available


    September 2021
  10. SUN Y, Mao H, Lou X, Wang X, et al
    Molecular epidemiologic characteristics of hemagglutinin from five waves of avian influenza A (H7N9) virus infection, from 2013 to 2017, in Zhejiang Province, China.
    Arch Virol. 2021 Sep 30. pii: 10.1007/s00705-021-05233.
    PubMed     Abstract available


  11. LAVERACK M, Tallmadge RL, Venugopalan R, Cronk B, et al
    Clinical evaluation of a multiplex real-time RT-PCR assay for detection of SARS-CoV-2 in individual and pooled upper respiratory tract samples.
    Arch Virol. 2021;166:2551-2561.
    PubMed     Abstract available


  12. NAGY A, Basiouni S, Parvin R, Hafez HM, et al
    Evolutionary insights into the furin cleavage sites of SARS-CoV-2 variants from humans and animals.
    Arch Virol. 2021;166:2541-2549.
    PubMed     Abstract available


  13. MARCHIO A, Batejat C, Vanhomwegen J, Feher M, et al
    ddPCR increases detection of SARS-CoV-2 RNA in patients with low viral loads.
    Arch Virol. 2021;166:2529-2540.
    PubMed     Abstract available


  14. ABDELWAHAB SF, Mohamed MK, Ali WY, Ali AS, et al
    Role of polymeric materials in preventing COVID-19 infection.
    Arch Virol. 2021;166:2487-2493.
    PubMed     Abstract available


  15. BOONARKART C, Suptawiwat O, Ruangrung K, Maneechotesuwan K, et al
    Microparticles from human the lower airway show inhibitory activity against respiratory syncytial virus.
    Arch Virol. 2021;166:2579-2584.
    PubMed     Abstract available


  16. MA Y, Jiang H, Wan Z, Li S, et al
    Evolutionary dynamics of group A and B respiratory syncytial virus in China, 2009-2018.
    Arch Virol. 2021;166:2407-2418.
    PubMed     Abstract available


    August 2021
  17. PENG J, Liu ZY, Yu XJ, Chen XY, et al
    Antibody response in COVID-19 patients with and without re-positive RT-PCR results during the convalescent phase.
    Arch Virol. 2021;166:2299-2303.
    PubMed     Abstract available


  18. SHABBIR S, Raza MH, Arshad M, Khan MJ, et al
    The interplay between the immune system and SARS-CoV-2 in COVID-19 patients.
    Arch Virol. 2021;166:2109-2117.
    PubMed     Abstract available


  19. HASHEMI SMA, Thijssen M, Hosseini SY, Tabarraei A, et al
    Human gene polymorphisms and their possible impact on the clinical outcome of SARS-CoV-2 infection.
    Arch Virol. 2021;166:2089-2108.
    PubMed     Abstract available


  20. ZHANG L, Hou J, Ma FZ, Li J, et al
    The common risk factors for progression and mortality in COVID-19 patients: a meta-analysis.
    Arch Virol. 2021;166:2071-2087.
    PubMed     Abstract available


    July 2021
  21. ZHOU S, Mao N, Zhang Y, Cui A, et al
    Genetic analysis of human parainfluenza virus type 4 associated with severe acute respiratory infection in children in Luohe City, Henan Province, China, during 2017-2018.
    Arch Virol. 2021 Jul 6. pii: 10.1007/s00705-021-05154.
    PubMed     Abstract available


  22. YUAN HW, Wen HL
    Research progress on coronavirus S proteins and their receptors.
    Arch Virol. 2021;166:1811-1817.
    PubMed     Abstract available


  23. MIRZAEI R, Attar A, Papizadeh S, Jeda AS, et al
    The emerging role of probiotics as a mitigation strategy against coronavirus disease 2019 (COVID-19).
    Arch Virol. 2021;166:1819-1840.
    PubMed     Abstract available


    June 2021
  24. ZENG MS, Yu WD, Wang HX, Xu PP, et al
    Puerarin reduces impairment of intestinal and adipose immune responses to influenza virus infection in mice.
    Arch Virol. 2021 Jun 10. pii: 10.1007/s00705-021-05112.
    PubMed     Abstract available


  25. CHEN K, Kong M, Liu J, Jiao J, et al
    Rapid differential detection of subtype H1 and H3 swine influenza viruses using a TaqMan-MGB-based duplex one-step real-time RT-PCR assay.
    Arch Virol. 2021 Jun 6. pii: 10.1007/s00705-021-05127.
    PubMed     Abstract available


  26. ROKIC F, Trgovec-Greif L, Sucic N, Cemeljic N, et al
    Diverse SARS-CoV-2 variants preceded the initial COVID-19 outbreak in Croatia.
    Arch Virol. 2021;166:1735-1739.
    PubMed     Abstract available


  27. PEDREANEZ A, Mosquera-Sulbaran J, Munoz N
    SARS-CoV-2 infection represents a high risk for the elderly: analysis of pathogenesis.
    Arch Virol. 2021;166:1565-1574.
    PubMed     Abstract available


    May 2021
  28. TANG Y, Yang G, Li Y, Wang M, et al
    Protective effects of SP600125 on mice infected with H1N1 influenza A virus.
    Arch Virol. 2021 May 20. pii: 10.1007/s00705-021-05103.
    PubMed     Abstract available


  29. SOKOLOVA AS, Yarovaya OI, Baranova DV, Galochkina AV, et al
    Quaternary ammonium salts based on (-)-borneol as effective inhibitors of influenza virus.
    Arch Virol. 2021 May 13. pii: 10.1007/s00705-021-05102.
    PubMed     Abstract available


  30. SYLVERKEN AA, El-Duah P, Owusu M, Schneider J, et al
    Transmission of SARS-CoV-2 in northern Ghana: insights from whole-genome sequencing.
    Arch Virol. 2021;166:1385-1393.
    PubMed     Abstract available


    April 2021
  31. GONZALEZ-GARCIA LD, Martinez-Castillo M, Vargas-Pavia TA, Ulloa-Aguilar JM, et al
    Inhibition of AMP-activated protein kinase in respiratory syncytial virus infection activates lipid metabolism.
    Arch Virol. 2021;166:1177-1182.
    PubMed     Abstract available


    March 2021
  32. ZINYAKOV NG, Sosipatorova VY, Andriyasov AV, Ovchinnikova EV, et al
    Genetic analysis of genotype G57 H9N2 avian influenza virus isolate A/chicken/Tajikistan/2379/2018 recovered in Central Asia.
    Arch Virol. 2021 Mar 19. pii: 10.1007/s00705-021-05011.
    PubMed     Abstract available


  33. WOUK J, Rechenchoski DZ, Rodrigues BCD, Ribelato EV, et al
    Viral infections and their relationship to neurological disorders.
    Arch Virol. 2021;166:733-753.
    PubMed     Abstract available


  34. DOWLATSHAHI S, Shabani E, Abdekhodaie MJ
    Serological assays and host antibody detection in coronavirus-related disease diagnosis.
    Arch Virol. 2021;166:715-731.
    PubMed     Abstract available


  35. DABBOUS HM, Abd-Elsalam S, El-Sayed MH, Sherief AF, et al
    Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study.
    Arch Virol. 2021;166:949-954.
    PubMed     Abstract available


  36. VERMA J, Subbarao N
    A comparative study of human betacoronavirus spike proteins: structure, function and therapeutics.
    Arch Virol. 2021;166:697-714.
    PubMed     Abstract available


  37. SARKAR R, Mitra S, Chandra P, Saha P, et al
    Comprehensive analysis of genomic diversity of SARS-CoV-2 in different geographic regions of India: an endeavour to classify Indian SARS-CoV-2 strains on the basis of co-existing mutations.
    Arch Virol. 2021;166:801-812.
    PubMed     Abstract available


  38. HEMMAT N, Asadzadeh Z, Ahangar NK, Alemohammad H, et al
    The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV.
    Arch Virol. 2021;166:675-696.
    PubMed     Abstract available


    February 2021
  39. YANG F, Xiao Y, Liu F, Yao H, et al
    Isolation and characterization of two novel reassortant H5N6 avian influenza viruses from waterfowl in eastern China.
    Arch Virol. 2021 Feb 17. pii: 10.1007/s00705-021-04995.
    PubMed     Abstract available


  40. LI Y, Hu J, Lei J, Fan W, et al
    Development and application of a novel triplex protein microarray method for rapid detection of antibodies against avian influenza virus, Newcastle disease virus, and avian infectious bronchitis virus.
    Arch Virol. 2021 Feb 12. pii: 10.1007/s00705-021-04962.
    PubMed     Abstract available


  41. TSUNEKI-TOKUNAGA A, Kanai K, Itagaki A, Tsuchie H, et al
    Growth capability of epidemic influenza viruses in Japan since the 2009 H1N1 pandemic.
    Arch Virol. 2021 Feb 12. pii: 10.1007/s00705-021-04976.
    PubMed     Abstract available


    January 2021
  42. ALLKOFER A, Garvey M, Ryan E, Lyons R, et al
    Primary vaccination in foals: a comparison of the serological response to equine influenza and equine herpesvirus vaccines administered concurrently or 2 weeks apart.
    Arch Virol. 2021 Jan 7. pii: 10.1007/s00705-020-04846.
    PubMed     Abstract available


  43. SABBAGHI A, Zargar M, Zolfaghari MR, Motamedi-Sedeh F, et al
    Protective cellular and mucosal immune responses following nasal administration of a whole gamma-irradiated influenza A (subtype H1N1) vaccine adjuvanted with interleukin-28B in a mouse model.
    Arch Virol. 2021 Jan 6. pii: 10.1007/s00705-020-04900.
    PubMed     Abstract available


  44. NG KT, Takebe Y, Kamarulzaman A, Tee KK, et al
    Genome sequencing and phylogenetic reconstruction reveal a potential fourth rhinovirus species and its worldwide distribution.
    Arch Virol. 2021;166:225-229.
    PubMed     Abstract available


  45. ARANCIO W
    ceRNA analysis of SARS-CoV-2.
    Arch Virol. 2021;166:271-274.
    PubMed     Abstract available


  46. MOSQUERA-SULBARAN JA, Hernandez-Fonseca H
    Tetracycline and viruses: a possible treatment for COVID-19?
    Arch Virol. 2021;166:1-7.
    PubMed     Abstract available


    December 2020
  47. REHMAN S, Mahmood T, Aziz E, Batool R, et al
    Identification of novel mutations in SARS-COV-2 isolates from Turkey.
    Arch Virol. 2020;165:2937-2944.
    PubMed     Abstract available


    November 2020
  48. YANG X, Liang Y, Bamunuarachchi G, Xu Y, et al
    miR-29a is a negative regulator of influenza virus infection through targeting of the frizzled 5 receptor.
    Arch Virol. 2020 Nov 18. pii: 10.1007/s00705-020-04877.
    PubMed     Abstract available


  49. LIU B, Wang Y, Liu Y, Chen Y, et al
    Molecular evolution and characterization of hemagglutinin and neuraminidase of influenza A(H1N1)pdm09 viruses isolated in Beijing, China, during the 2017-2018 and 2018-2019 influenza seasons.
    Arch Virol. 2020 Nov 3. pii: 10.1007/s00705-020-04869.
    PubMed     Abstract available


  50. DADAR M, Fakhri Y, Bjorklund G, Shahali Y, et al
    The association between the incidence of COVID-19 and the distance from the virus epicenter in Iran.
    Arch Virol. 2020;165:2555-2560.
    PubMed     Abstract available


  51. SHAMIM S, Khan M, Kharaba ZJ, Ijaz M, et al
    Potential strategies for combating COVID-19.
    Arch Virol. 2020;165:2419-2438.
    PubMed     Abstract available


    October 2020
  52. GROHN S, Heinimaki S, Tamminen K, Blazevic V, et al
    Expression of influenza A virus-derived peptides on a rotavirus VP6-based delivery platform.
    Arch Virol. 2020 Oct 16. pii: 10.1007/s00705-020-04847.
    PubMed     Abstract available


  53. CAROSSINO M, Ip HS, Richt JA, Shultz K, et al
    Detection of SARS-CoV-2 by RNAscope((R)) in situ hybridization and immunohistochemistry techniques.
    Arch Virol. 2020;165:2373-2377.
    PubMed     Abstract available


  54. GALLAHER WR
    A palindromic RNA sequence as a common breakpoint contributor to copy-choice recombination in SARS-COV-2.
    Arch Virol. 2020;165:2341-2348.
    PubMed     Abstract available


  55. JANG Y, Seo SH
    Gene expression pattern differences in primary human pulmonary epithelial cells infected with MERS-CoV or SARS-CoV-2.
    Arch Virol. 2020;165:2205-2211.
    PubMed     Abstract available


    September 2020
  56. GARCES-AYALA F, Araiza-Rodriguez A, Mendieta-Condado E, Rodriguez-Maldonado AP, et al
    Full genome sequence of the first SARS-CoV-2 detected in Mexico.
    Arch Virol. 2020;165:2095-2098.
    PubMed     Abstract available


    August 2020
  57. KETKLAO S, Boonarkart C, Phakaratsakul S, Auewarakul P, et al
    Responses to the Sb epitope contributed to antigenic drift of the influenza A 2009 H1N1 virus.
    Arch Virol. 2020 Aug 11. pii: 10.1007/s00705-020-04758.
    PubMed     Abstract available


  58. LIMA WG, Brito JCM, Overhage J, Nizer WSDC, et al
    The potential of drug repositioning as a short-term strategy for the control and treatment of COVID-19 (SARS-CoV-2): a systematic review.
    Arch Virol. 2020;165:1729-1737.
    PubMed     Abstract available


  59. MCIVER DJ, Silithammavong S, Theppangna W, Gillis A, et al
    Coronavirus surveillance of wildlife in the Lao People's Democratic Republic detects viral RNA in rodents.
    Arch Virol. 2020;165:1869-1875.
    PubMed     Abstract available


    July 2020
  60. DA COSTA VG, Moreli ML, Saivish MV
    The emergence of SARS, MERS and novel SARS-2 coronaviruses in the 21st century.
    Arch Virol. 2020;165:1517-1526.
    PubMed     Abstract available


    June 2020
  61. KOLOSOVA NP, Ilyicheva TN, Danilenko AV, Svyatchenko SV, et al
    Severe cases of seasonal influenza and detection of seasonal A(H1N2) in Russia in 2018-2019.
    Arch Virol. 2020 Jun 10. pii: 10.1007/s00705-020-04699.
    PubMed     Abstract available


    May 2020
  62. YUN KW, Choi EH, Lee HJ
    Molecular epidemiology of respiratory syncytial virus for 28 consecutive seasons (1990-2018) and genetic variability of the duplication region in the G gene of genotypes ON1 and BA in South Korea.
    Arch Virol. 2020;165:1069-1077.
    PubMed     Abstract available


  63. LI H, Cao L, Zhang Y, Ren H, et al
    Human respiratory syncytial virus F protein expressed in Pichia pastoris or Escherichia coli induces protective immunity without inducing enhanced respiratory disease in mice.
    Arch Virol. 2020;165:1057-1067.
    PubMed     Abstract available


    April 2020
  64. ARBI M, Souiai O, Rego N, Larbi I, et al
    Historical origins and zoonotic potential of avian influenza virus H9N2 in Tunisia revealed by Bayesian analysis and molecular characterization.
    Arch Virol. 2020 Apr 25. pii: 10.1007/s00705-020-04624.
    PubMed     Abstract available


  65. YEHIA N, Hassan WMM, Sedeek A, Elhusseiny MH, et al
    Genetic variability of avian influenza virus subtype H5N8 in Egypt in 2017 and 2018.
    Arch Virol. 2020 Apr 13. pii: 10.1007/s00705-020-04621.
    PubMed     Abstract available


    March 2020
  66. LIMSUWAT N, Boonarkart C, Phakaratsakul S, Suptawiwat O, et al
    Influence of cellular lipid content on influenza A virus replication.
    Arch Virol. 2020 Mar 29. pii: 10.1007/s00705-020-04596.
    PubMed     Abstract available


  67. JANG Y, Seo T, Seo SH
    Higher virulence of swine H1N2 influenza viruses containing avian-origin HA and 2009 pandemic PA and NP in pigs and mice.
    Arch Virol. 2020 Mar 28. pii: 10.1007/s00705-020-04572.
    PubMed     Abstract available


  68. YANG F, Xiao Y, Xu L, Liu F, et al
    Development of an antigen-capture enzyme-linked immunosorbent assay and immunochromatographic strip based on monoclonal antibodies for detection of H6 avian influenza viruses.
    Arch Virol. 2020 Mar 27. pii: 10.1007/s00705-020-04602.
    PubMed     Abstract available


  69. SIMMONDS P, Gorbalenya AE, Harvala H, Hovi T, et al
    Recommendations for the nomenclature of enteroviruses and rhinoviruses.
    Arch Virol. 2020;165:793-797.
    PubMed     Abstract available


    February 2020
  70. RAMIREZ-SALINAS GL, Garcia-Machorro J, Rojas-Hernandez S, Campos-Rodriguez R, et al
    Bioinformatics design and experimental validation of influenza A virus multi-epitopes that induce neutralizing antibodies.
    Arch Virol. 2020 Feb 14. pii: 10.1007/s00705-020-04537.
    PubMed     Abstract available


    January 2020
  71. KHALIL AM, Nishi N, Kojima I, Fukunaga W, et al
    Transition in genetic constellations of H3N8 and H4N6 low-pathogenic avian influenza viruses isolated from an overwintering site in Japan throughout different winter seasons.
    Arch Virol. 2020 Jan 10. pii: 10.1007/s00705-019-04519.
    PubMed     Abstract available


    November 2019
  72. EVSEENKO VA, Svyatchenko SV, Kolosova NP, Kovrizhkina VL, et al
    Comparative thermostability analysis of zoonotic and human influenza virus A and B neuraminidase.
    Arch Virol. 2019 Nov 19. pii: 10.1007/s00705-019-04465.
    PubMed     Abstract available


  73. TWABELA AT, Okamatsu M, Tshilenge GM, Mpiana S, et al
    Molecular, antigenic, and pathogenic characterization of H5N8 highly pathogenic avian influenza viruses isolated in the Democratic Republic of Congo in 2017.
    Arch Virol. 2019 Nov 9. pii: 10.1007/s00705-019-04456.
    PubMed     Abstract available


  74. ZELL R, Groth M, Krumbholz A, Lange J, et al
    Displacement of the Gent/1999 human-like swine H1N2 influenza A virus lineage by novel H1N2 reassortants in Germany.
    Arch Virol. 2019 Nov 6. pii: 10.1007/s00705-019-04457.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: